Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
Globalization and Access to Drugs. Perspectives on the WTO/TRIPS Agreement - Health Economics and Drugs Series, No. 007 (Revised)
(1998; 97 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentAcknowledgements
View the documentAbbreviations and acronyms
Open this folder and view contentsPART I: GLOBALIZATION AND ACCESS TO DRUGS: IMPLICATIONS OF THE WTO/TRIPS AGREEMENT
Open this folder and view contentsPART II: PRESENTATIONS AT THE AD HOC WORKING GROUP ON THE REVISED DRUG STRATEGY HELD IN GENEVA ON 13 OCTOBER 1998
View the documentOther documents in the DAP - Health Economics and Drugs Series
View the documentBack cover
 

Other documents in the DAP - Health Economics and Drugs Series

No. 1

Alternative drug pricing policies in the Americas

No. 2

The public and private circuits for the distribution of drugs in the Chilean health system

No. 3

Global comparative pharmaceutical expenditures

No. 4

Financing drugs in South-East Asia. Report of the first meeting of the WHO/SEARO Working Group on Drug Financing

No. 5

Public-private roles in the pharmaceutical sector. Implications for equitable access and rational drug use

No. 6

Health reform and drug financing. Selected topics

 

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: November 5, 2014